21008 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin Corticotropin [ACTH]
METHODS OF PROMOTING REMYELINATION
#2PRE-FILLED MANUAL INJECTOR APPARATUS
#3MATERIALS AND METHODS FOR TREATING STRESS-RELATED DISORDERS AND CANCER
#4DRUG CONTAINING ADRENOCORTICOTROPIC HORMONE OR DERIVATIVE THEREOF AND USE THEREOF
#5INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF
#6Formulation Including a Combination of beta-Endorphin and Adrenocorticotropic Hormone
#7METHODS OF PROMOTING REMYELINATION
#8Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
#9Formulation Including a Combination of beta-Endorphin and Adrenocorticotropic Hormone
#10Materials and methods for treating stress-related disorders and cancer
#11METHODS OF MODULATING CORTICOSTEROID RESPONSE
#12Formulation including a combination of beta-endorphin and adrenocorticotropic hormone
#13METHODS FOR TREATING TRAUMATIC BRAIN INJURY
#14Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof
#15ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS
#16ACTH FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME
#17Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof
#18PREPARATION METHOD OF SUSTAINED-RELEASE MICROPARTICLES
#19Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
#20ACTH FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#21ADRENOCORTICOTROPIC HORMONE-BASED PHARMACEUTICAL FORMULATIONS AND METHODS FOR FABRICATING AND USING THEREOF
#22SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#23ACTH prophylactic treatment of renal disorders
#24BIOERODIBLE SILICON-BASED DELIVERY VEHICLES FOR DELIVERY OF THERAPEUTIC AGENTS
#25Solvent/polymer solutions as suspension vehicles
#26Oral administration of tocilizumab treatment of autoimmune disease
#27Combination of a MC1R receptor agonist and UVB for the treatment and/or prevention of pigmentation disorders
#28Combination of a prostaglandin receptor agonist and an MC1R receptor agonist for the treatment and/or prevention of pigmentation disorders
#29ACTH prophylactic treatment of renal disorders
#30ACTH for treatment of acute respiratory distress syndrome
#31Bioerodible Silicon-Based Delivery Vehicles for Delivery of Therapeutic Agents
#32TREATMENT OF HIV
#33ACTH FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#34TREATMENT OF HIV
#35Solvent/polymer solutions as suspension vehicles
#36Solvent/polymer solutions as suspension vehicles
#37Methods of treating overproduction of cortisol using ACTH antagonist peptides
#38Solvent/polymer solutions as suspension vehicles
#39TREATMENT OF HIV
#40Solvent/polymer solutions as suspension vehicles
#41Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
#42AGENTS FOR THE TREATMENT OF MULTIPLE SCLEROSIS AND METHODS OF USING SAME
#43SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#44USE OF FIBRONECTIN FRAGMENT (196-203 ) AS A THERAPEUTIC AGENT
#45THERAPEUTIC USE OF NEUROPEPTIDE EI AND ACTH 7-38 AND COMPOSITIONS THEREOF
#46USE OF UROCORTIN AND CORTICOTROPIN-RELEASING FACTOR AS THERAPEUTIC AGENTS
#47Use of the peptide RFMWMR as a therapeutic agent
#48USE OF TRP6-TRIPTORELIN AND D-LEU6-LEUPROLIDE AS THERAPEUTIC AGENTS
#49USE OF LVV-HEMORPHIN-6 AND OPTIONALLY AF12198 AS THERAPEUTIC AGENT(S)
#50THERAPEUTIC USES OF PEPTIDES YSAYPDSVPMMS and WMNSTGFTKVCGAPPC
#51USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#52USE OF PEPTIDE AS A THERAPEUTIC AGENT
#53USE OF A COMBINATION OF CART PEPTIDES AS A THERAPEUTIC AGENT
#54Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)
#55Anti-hemorrhage medication pack
#56Treatment of HIV
#57METHOD OF PREVENTING AND TREATING ENDOCRINE SYSTEM DISTURBANCES
#58SARMS and method of use thereof
#59Methods and compositions for treatment of viral infections
#60Solvent/polymer solutions as suspension vehicles
#61Medicinal Agent for Preventing and Treating Endocrine System Disturbances
#62Compound and method of treatment for fungal pathologies of the oral cavity
#63Methods and reagents for treating neurodegenerative diseases and motor deficit disorders
#64Composition and apparatus for transdermal delivery
#65Kits for preparing and delivering purified corticotropin
#66Kits for preparing and delivering purified corticotropin
#67Kits for preparing and delivering purified corticotropin
#68Methods of modulating pericytes